University of Minnesota
University Imaging Center
University Imaging Centers - Where the University sees the future

Siemens Inveon µPET/CT

Equipment Type: 
UMN Rate: 
Please Contact UIC Staff.
PDF icon Inveon manual13.14 MB
PDF icon Inveon User Notes1.63 MB
PDF icon Inveon Site Guide4.67 MB
PDF icon Inveon Description52.86 KB
PDF icon New User Guide67.57 KB


February 21, 2019.

Dear Users of the Siemens Inveon µPET/CT,

As a user of the µPET/CT in the University Imaging Centers (UIC), I need to alert you to our decision to stop offering µPET/CT services. The µPET/CT will be decommissioned May 31, 2019.

The average revenue from last fiscal year was ~$12,000 and a similar level of revenues is projected for FY19. The yearly expenses are $100,000.  Over half of the expense ($55,000) is for the annual service agreement, with the remaining expenses for labor, supplies and software fees.  Since transferring the µPET/CT under UIC’s management in 2016, the Medical School and UIC have been heavily subsidizing the costs of operating the µPET/CT.

The decision to remove the µPET/CT has been a difficult one. However, the UIC cannot continue to sustain an $85,000 annual operating deficits on this instrument. Hopefully, this notice will provide the time needed to make other arrangements for your future µPET/CT imaging needs. Discussions for extending Inveon PET/CT operations would need to come with guaranteed user fees. I suggest you consult with Mark Sanders, Director of the UIC, on other options for small and large animal imaging services in Minnesota. 



Timothy J. Ebner, M.D., Ph.D.

Professor and Head

Department of Neuroscience


Getting Started:

To schedule an initial PET/CT imaging consultation please contact:

Instrument Overview:

A Siemens Inveon preclinical microPET/CT now augments the center's extensive MR capabilities. microPET/CT is a molecular level functional imaging modality that provides valuable insight into biochemical, physiological, pathological and/or pharmacological processes in vivo. The microPET/CT can be used in a number of ways. This information can be obtained via a non-invasive, in vivo imaging process that allows both serial and longitudinal studies to be performed and in a continuous and comparative way. Other areas can be assessed such as novel drug delivery, effects of intervention, and progression and outcome of a particular therapy. Examples of biomedical applications specific to the microPET/CT using FDG:

  • Myocardial viability.
  • Tumor glucose metabolism.
  • Gastrointestinal graft-versus-host disease (GVHD).
  • Neurotransmitter function in vivo over time, e.g. Huntington's, Parkinson's, Alzheimer's disease.
  • Time-activity profiles reflecting tracer delivery, binding and washout, i.e., pharmokinetics.
  • Development of new radiopharmaceuticals for use in diagnostic imaging and new molecular imaging assays.
  • Acquisition of sequential PET and CT data without repositioning.